Ringing relief? migraine drugs tested for tinnitus in new study

NCT ID NCT07655440

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

Many people with migraine also suffer from tinnitus, a persistent ringing in the ears. This trial will compare two types of migraine preventives—newer anti-CGRP drugs and older medications like antidepressants and blood pressure drugs—to see which better reduces tinnitus symptoms. 120 adults with both conditions will be randomly assigned to one of the two groups and followed for 24 weeks. The study is run by Stanford University and is not yet recruiting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
migraine preventive medications (anti-CGRP drugs like galcanezumab, erenumab, eptinezumab, atogepant; and conventional drugs like amitriptyline, nortriptyline, propranolol, verapamil)
What this could lead to
If it works, this could point toward a new treatment option for tinnitus in people with migraine, potentially reducing the ringing in their ears.
What could go wrong
This is a Phase 4 trial with only 120 participants, so results may not apply to everyone. It is also possible that neither drug class helps tinnitus more than the other.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIGRAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.